Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitorsmarket, defines the market attractiveness level of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors industry, describes the types of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market and the development prospects and opportunities of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market in Chapter 13.
By Player:
Puma Biotechnology Inc
Merck & Co Inc
Pfizer Inc
Novartis AG
F Hoffmann-La Roche Ltd
By Type:
Monotherapy
Combination Therapy
By End-User:
Breast Cancer
Gastric Cancer
Ovarian Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption (2017-2022)
-
7.2 United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption (2017-2022)
-
7.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption (2017-2022)
-
7.4 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption (2017-2022)
-
7.5 Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption (2017-2022)
-
7.6 India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption (2017-2022)
-
7.7 South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption (2017-2022)
8 Region and Country-wise HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast (2022-2028)
-
8.4 China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast (2022-2028)
-
8.6 India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast (2022-2028)
9 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Gastric Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Competitive Analysis
-
14.1 Puma Biotechnology Inc
-
14.1.1 Puma Biotechnology Inc Company Details
-
14.1.2 Puma Biotechnology Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Puma Biotechnology Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
14.2 Merck & Co Inc
-
14.2.1 Merck & Co Inc Company Details
-
14.2.2 Merck & Co Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck & Co Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Details
-
14.3.2 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
14.4 Novartis AG
-
14.4.1 Novartis AG Company Details
-
14.4.2 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Details
-
14.5.2 F Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors
-
Figure HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Picture
-
Table Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption by Country (2017-2022)
-
Figure United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastric Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Puma Biotechnology Inc (Foundation Year, Company Profile and etc.)
-
Table Puma Biotechnology Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Puma Biotechnology Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product and Service
-
